3 FORMULAtions
Medications personalized
for your patients
for your patients
Weight Loss
Clinical Note
Due to evolving regulatory guidance on bulk compounding, we no longer offer standalone semaglutide or tirzepatide preparations. However, these medications may still be compounded as part of a multi-ingredient formulation when clinically justified. We currently offer the above glycine-based combinations, intended for prescribers seeking personalized options for patients who have not tolerated commercial products, require modified dosing, or may benefit from individualized treatment strategies.
Prescriber Inquiry Areas
Prescribers commonly ask about individualized low-dose regimens in connection
with patient-specific care plans involving:
Immune-mediated concerns
Pain or neuropathy discussions
Fatigue-related syndromes
Fibromyalgia
Thyroid autoimmunity
Neurologic or inflammatory concerns
Gastrointestinal inflammatory concerns
Elements does not present LDN as a treatment for any listed condition.
Prescribers are responsible for clinical evaluation, diagnosis, and treatment decisions.
Dermatology + Hair Loss
Additional compounded dermatology, anti-aging, and hair-loss formulations will be added as the portal catalog expands.
Coming Soon
Dermatology, anti-aging, and hair-loss categories are next in the expanded medication catalog.
Topical dermatology formulations
Hair-loss formulations
Prescriber-focused catalog pages